The National Marrow Donor Program's Symposium on Patient Advocacy in Cellular Transplantation Therapy: Addressing Barriers to Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

The National Marrow Donor Program's Symposium on Patient Advocacy in Cellular Transplantation Therapy: Addressing Barriers to Hematopoietic Cell Transplantation

Published:2010-02 Issue:2 Volume:16 Page:147-156
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Murphy Elizabeth A.,Ferguson Stacy Stickney,Omondi Nancy Atieno,Getzendaner Lisa C.,Gajewski James L.,Goldstein Gary A.,Wingard John R.,Rizzo J. Douglas,Mahjail Navneet S.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference22 articles.

1. The National Marrow Donor Program: 20 years of unrelated donor hematopoietic cell transplantation;Ballen;Biol Blood Marrow Transplant,2008

2. Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program;Karanes;Biol Blood Marrow Transplant,2008

3. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation;Lee;Blood,2007

4. Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program;MacMillan;Biol Blood Marrow Transplant,2008

5. CIBMTR summary slides 2007 (part 2);Pasquini;CIBMTR Newslett,2008

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unrelated hematopoietic stem cell donor registries: present reality and future prospects;Current Opinion in Hematology;2024-07-22

2. Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research;Transplantation and Cellular Therapy;2023-06

3. Reducing barriers of access and care related to hematopoietic cell transplantation and cellular therapy: The mission-driven role of the national marrow donor program;Best Practice & Research Clinical Haematology;2023-06

4. Clinical Outcomes of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia in a County Hospital System;Clinical Lymphoma Myeloma and Leukemia;2021-11

5. Likelihood of Proceeding to Allogeneic Hematopoietic Cell Transplantation in the United States after Search Activation in the National Registry: Impact of Patient Age, Disease, and Search Prognosis;Transplantation and Cellular Therapy;2021-02